Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xingya Li

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Discover Oncology|October 24, 2024
UBE2C promotes LUAD progression by ubiquitin-dependent degradation of p53 to inactivate the p53/p21 signaling pathwaySiyuan Huang, Xingya Li
Pharmaceutics|September 14, 2018
Amorphous Nanoparticulate Formulation of Sirolimus and Its TabletsYudong Shen, Xingya Li, Yuan Le
BMC Pulmonary Medicine|May 19, 2023
Efficacy and safety of combined immunotherapy and antiangiogenic therapy for advanced non-small cell lung cancer: a real-world observation studyKe Ma, Qianqian Guo, Xingya Li
Frontiers in Oncology|June 5, 2024
Association of PD-L1 expression and clinical outcomes in ROS1 - rearranged advanced non-small cell lung cancer treated with crizotinibHuixian Zhang, Ziheng Zhang, Ningning Yan, et al.
Molecular Biotechnology|May 11, 2024
A Novel Neutrophil Extracellular Trap Signature Predicts Patient Chemotherapy Resistance and Prognosis in Lung AdenocarcinomaLong Xing, Shuangli Wu, Shiyue Xue, et al.
Oncotargets and Therapy|June 30, 2021
Cholesterol Metabolism as a Potential Therapeutic Target and a Prognostic Biomarker for Cancer ImmunotherapyHuixian Zhang, Wencheng Zhao, Xingya Li, et al.
Frontiers in Neurology|June 12, 2026
REM sleep proportion: an independent predictor of olfactory dysfunction in obstructive sleep apnea hypopnea syndromeYuanquan Li, Renli Huang, Xingya Li, et al.
Cancer Cell International|December 15, 2020
Exosomal miR-126 blocks the development of non-small cell lung cancer through the inhibition of ITGA6Mingjun Li, Qianqian Wang, Xiaofei Zhang, et al.
National Science Review|January 20, 2025
Constructing new-generation ion exchange membranes under confinement regimeXingya Li, Peipei Zuo, Xiaolin Ge, et al.
Oncology Letters|February 15, 2024
Efficacy of immune checkpoint inhibitors in advanced large cell neuroendocrine carcinoma of the lung: A single‑institution experienceNingning Yan, Sanxing Guo, Ziheng Zhang, et al.
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Discover Oncology|October 24, 2024
UBE2C promotes LUAD progression by ubiquitin-dependent degradation of p53 to inactivate the p53/p21 signaling pathwaySiyuan Huang, Xingya Li
Pharmaceutics|September 14, 2018
Amorphous Nanoparticulate Formulation of Sirolimus and Its TabletsYudong Shen, Xingya Li, Yuan Le
BMC Pulmonary Medicine|May 19, 2023
Efficacy and safety of combined immunotherapy and antiangiogenic therapy for advanced non-small cell lung cancer: a real-world observation studyKe Ma, Qianqian Guo, Xingya Li
Frontiers in Oncology|June 5, 2024
Association of PD-L1 expression and clinical outcomes in ROS1 - rearranged advanced non-small cell lung cancer treated with crizotinibHuixian Zhang, Ziheng Zhang, Ningning Yan, et al.
Molecular Biotechnology|May 11, 2024
A Novel Neutrophil Extracellular Trap Signature Predicts Patient Chemotherapy Resistance and Prognosis in Lung AdenocarcinomaLong Xing, Shuangli Wu, Shiyue Xue, et al.
Oncotargets and Therapy|June 30, 2021
Cholesterol Metabolism as a Potential Therapeutic Target and a Prognostic Biomarker for Cancer ImmunotherapyHuixian Zhang, Wencheng Zhao, Xingya Li, et al.
Frontiers in Neurology|June 12, 2026
REM sleep proportion: an independent predictor of olfactory dysfunction in obstructive sleep apnea hypopnea syndromeYuanquan Li, Renli Huang, Xingya Li, et al.
Cancer Cell International|December 15, 2020
Exosomal miR-126 blocks the development of non-small cell lung cancer through the inhibition of ITGA6Mingjun Li, Qianqian Wang, Xiaofei Zhang, et al.
National Science Review|January 20, 2025
Constructing new-generation ion exchange membranes under confinement regimeXingya Li, Peipei Zuo, Xiaolin Ge, et al.
Oncology Letters|February 15, 2024
Efficacy of immune checkpoint inhibitors in advanced large cell neuroendocrine carcinoma of the lung: A single‑institution experienceNingning Yan, Sanxing Guo, Ziheng Zhang, et al.
Pageof 15